Eur Respir J 2005; 25:221-224
Copyright ©ERS Journals Ltd 2005
Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
G. M. Verleden1,
L. J. Dupont1 and
D. E. Van Raemdonck2
1 Depts of Respiratory Diseases and Lung Transplantation Unit, and 2 Dept of Thoracic Surgery, University Hospital Gasthuisberg 49, Herestraat, B-3000 Leuven, Belgium
CORRESPONDENCE: G. M. Verleden, University Hospital Gasthuisberg, Dept of Respiratory Diseases and Lung Transplantation Unit 49, Herestraat, B-3000 Leuven, Belgium. Fax: 32 16346803. E-mail: geert.verleden@uz.kuleuven.ac.be
Keywords: Bronchiolitis obliterans syndrome, chronic rejection, lung transplantation
Received: May 13, 2004
Accepted October 2, 2004
Chronic rejection (obliterative bronchiolitis) is the single most important cause of chronic allograft dysfunction and late mortality after lung transplantation. As this condition is difficult to prove using biopsy specimens, a clinical term, bronchiolitis obliterans syndrome (BOS) has been in use for >10 yrs to describe the progressive decrease of pulmonary function. However, before diagnosing a patient as having BOS, based on a sustained and progressive decrease in forced expiratory volume in one second and/or forced mid-expiratory flow between 2575% of forced vital capacity, different confounding factors have to be eliminated.
Treatment of BOS mainly consists of an increase or a change in the immunosuppressive drug regimen, which may lead to more pronounced infectious complications. Recently, two new options have become available to treat patients with BOS, treatment of gastro-oesophageal reflux and azithromycin.
In the present paper, the authors give an overview of the current data on these two modalities, which may lead to a restoration of the pulmonary function in some of the patients, illustrating once more the fact that bronchitis obliterans syndrome is not always a manifestation of chronic rejection.
This article has been cited by other articles:

|
 |

|
 |
 
J. A. Belperio, S. S. Weigt, M. C. Fishbein, and J. P. Lynch III
Chronic Lung Allograft Rejection: Mechanisms and Therapy
Proceedings of the ATS,
January 15, 2009;
6(1):
108 - 121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Vanaudenaerde, I. Meyts, R. Vos, N. Geudens, W. De Wever, E. K. Verbeken, D. E. Van Raemdonck, L. J. Dupont, and G. M. Verleden
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy
Eur. Respir. J.,
October 1, 2008;
32(4):
832 - 842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Vanaudenaerde, R. Vos, N. Geudens, D. Van Raemdonck, L. Dupont, and G. Verleden
The Leuven experience with a dichotomy in Bronchiolitis Obliterans Syndrome (BOS) after lung transplantation revealed by azithromycin
Eur. Respir. Rev.,
June 1, 2008;
17(108):
93 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-K. Song, A. De Vito Dabbs, S. M. Studer, and S. E. Zangle
Course of Illness after the Onset of Chronic Rejection in Lung Transplant Recipients
Am. J. Crit. Care.,
May 1, 2008;
17(3):
246 - 253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Blondeau, V. Mertens, B. A. Vanaudenaerde, G. M. Verleden, D. E. Van Raemdonck, D. Sifrim, and L. J. Dupont
Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection
Eur. Respir. J.,
April 1, 2008;
31(4):
707 - 713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Cordier
Challenges in pulmonary fibrosis {middle dot} 2 : Bronchiolocentric fibrosis
Thorax,
July 1, 2007;
62(7):
638 - 649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Ward, I A Forrest, I A Brownlee, G E Johnson, D M Murphy, J P Pearson, J H Dark, and P A Corris
Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts
Thorax,
October 1, 2005;
60(10):
872 - 874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Williams and G. M. Verleden
Azithromycin: A Plea for Multicenter Randomized Studies in Lung Transplantation
Am. J. Respir. Crit. Care Med.,
September 15, 2005;
172(6):
657 - 659.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the European Respiratory Society.
|